logo

For the Inventor, By the Inventor

East Lyme, CT, United States of America

Steven Victor O'Neil

This inventor holds 22 USPTO granted patents and 13 published patent applications and 7 EPO patents, primarily in Dopamine D1 Ligands. Top assignee: Pfizer Corporation. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Victor O'Neil. Retrieved from https://idiyas.com/inventor/steven-victor-o-neil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.9

ph-index = 5

Forward Citations = 68(Granted Patents)


Company Filing History:

goldMedal22 out of 4,488 
 
Pfizer Corporation
 patents

Years Active: 2014-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Heteroaromatic Compounds
Dopamine D1 Ligands
MAGL Inhibitors
Heterocyclic Compounds
Fluorinated Derivatives
Pharmacology
Chemical Synthesis
Bioactive Molecules
Drug Discovery
Medicinal Chemistry
22 patents (USPTO):Explore Patents
1. 11964961 - Heteroaromatic compounds and their use as dopamine D1 ligands (2024-04-23),
2. 11014909 - Heteroaromatic compounds and their use as dopamine D1 ligands (2021-05-25),
3. 10858373 - Heterocyclic spiro compounds as MAGL inhibitors (2020-12-08),
4. 10723711 - 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (2020-07-28),
5. 10696658 - Heteroaromatic compounds and their use as dopamine D1 ligands (2020-06-30),
6. 10626125 - 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors (2020-04-21),
7. 10428034 - 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (2019-10-01),
8. 10421744 - Heteroaromatic compounds and their use as dopamine D1 ligands (2019-09-24),
9. 10329308 - 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors (2019-06-25),
10. 10093655 - Heteroaromatic compounds and their use as dopamine D1 ligands (2018-10-09),
11. 10077272 - Heteroaromatic compounds and their use as dopamine D1 ligands (2018-09-18),
12. 9868744 - Heteroaromatic compounds and their use as dopamine D1 ligands (2018-01-16),
13. 9845301 - 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (2017-12-19),
14. 9822097 - Heteroaromatic compounds and their use as dopamine D1 ligands (2017-11-21),
15. 9745317 - Heterocyclic compounds and their use as dopamine D1 ligands (2017-08-29),

Title: The Innovative Journey of Steven Victor O'Neil

Introduction: Steven Victor O'Neil, a talented inventor hailing from East Lyme, CT (US), has made significant contributions to the world of innovations with his creative mind and dedication.

Latest Patents: Steven Victor O'Neil holds several patents in various fields, including technology, healthcare, and consumer products. His recent patents focus on cutting-edge solutions for everyday challenges, showcasing his commitment to improving lives through innovation.

Career Highlights: Throughout his illustrious career, Steven Victor O'Neil has been recognized for his groundbreaking inventions that have revolutionized industries. His ability to think outside the box and turn ideas into reality has set him apart as a visionary inventor.

Collaborations: Steven Victor O'Neil has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in bringing innovative products to the market and making a positive impact on society.

Conclusion: Steven Victor O'Neil's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventions. His remarkable contributions continue to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…